4//SEC Filing
MCENANY PATRICK J 4
Accession 0001161697-24-000447
CIK 0001369568other
Filed
Nov 14, 7:00 PM ET
Accepted
Nov 15, 5:00 PM ET
Size
14.7 KB
Accession
0001161697-24-000447
Insider Transaction Report
Form 4
MCENANY PATRICK J
DirectorPresident and CEO10% Owner
Transactions
- Exercise/Conversion
Common stock, par value $0.001 per share
2024-11-13$3.54/sh+92,500$327,450→ 4,570,669 total - Sale
Common stock, par value $0.001 per share
2024-11-13$22.98/sh−92,500$2,125,465→ 4,478,169 total - Exercise/Conversion
Common stock, par value $0.001 per share
2024-11-14$3.54/sh+44,655$158,079→ 4,522,824 total - Sale
Common stock, par value $0.001 per share
2024-11-14$21.75/sh−44,655$971,336→ 4,478,169 total - Exercise/Conversion
Options to purchase common stock
2024-11-13−92,500→ 2,008,245 totalExercise: $3.54Exp: 2025-05-29→ Common Stock (92,500 underlying) - Exercise/Conversion
Options to purchase common stock
2024-11-14−44,655→ 1,963,590 totalExercise: $3.54Exp: 2025-05-29→ Common Stock (44,655 underlying)
Footnotes (4)
- [F1]Shares were sold for personal reasons, including paying federal income taxes and diversifying the Reporting Person's portfolio. Shares were not sold as a result of any disagreement with the Company. Mr. McEnany remains the non-executive chairman of the Company's Board of Directors and the Company's largest individual, non-institutional shareholder.
- [F2]Represents a weighted average price for the shares sold. Shares were sold in various lots ranging from $22.82 to $23.13 per share.
- [F3]Represents a weighted average price for the shares sold. Shares were sold in various lots ranging from $21.52 to $22.20 per share.
- [F4]Options vested in three equal tranches on May 29, 2019, 2020 and 2021.
Documents
Issuer
CATALYST PHARMACEUTICALS, INC.
CIK 0001369568
Entity typeother
Related Parties
1- filerCIK 0000929985
Filing Metadata
- Form type
- 4
- Filed
- Nov 14, 7:00 PM ET
- Accepted
- Nov 15, 5:00 PM ET
- Size
- 14.7 KB